SWA
MRNA icon

Sax Wealth Advisors’s Moderna MRNA Stock Holding History

Sax Wealth Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-972
Closed -$247K – 183
2021
Q4 		$247K Hold
972
– – 0.05% 157
2021
Q3 		$374K Hold
972
– – 0.09% 118
2021
Q2 		$228K Buy
+972
New +$174K 0.08% 143
2021
Q1 		– Sell
-1,932
Closed -$202K – 151
2020
Q4 		$202K Buy
+1,932
New +$195K 0.09% 126

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sax Wealth Advisors's MRNA Position: Q1 2022 in Review

Sax Wealth Advisors sold out of Moderna (MRNA) in Q1 2022, closing a stake of 972 shares — an estimated $247K sold.

Sax Wealth Advisors first reported a position in MRNA in Q4 2020 and held it in 4 quarters. The position peaked at $374K in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Sax Wealth Advisors reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Sax Wealth Advisors sold 972 Moderna shares in Q1 2022, an estimated $247K.
  • Sax Wealth Advisors first reported a position in Moderna in Q4 2020 and held it in 4 quarters.
  • Sax Wealth Advisors's Moderna position peaked at $374K in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Sax Wealth Advisors's 13F filing for Q1 2022, filed 20 Apr 2022.